|
|
||||||||

Deceased.
Address correspondence and reprint requests to Dr. Chris C. Plato, Department of Neurosciences, University of California San Diego School of Medicine, 9500 Gilman Drive, La Jolla, CA 92093-0624; e-mail: drccplato{at}mindspring.com
Background: It was noticed in the mid-1950s that the incidence of ALS and parkinsonismdementia complex (PDC) were much higher on Guam than anywhere else in the world. In 1958, a registry of patients and controls was established to ascertain the familial and genetic aspects of these diseases. Patients and individually matched controls and their relatives were registered from 1958 to 1963. The registry was updated and analyzed in 1998 through 1999.
Objective: To ascertain whether first-degree relatives of patients had a higher risk for developing ALS or PDC than relatives of controls.
Methods: During the period of 1958 to 1963, 126 new patients and 126 individually matched controls and their respective first-degree relatives and spouses were evaluated neurologically and registered. Forty years later, the number of new cases among the patient and control relatives were compared to an expected number of new cases based on the age- and sex-specific incidence of ALS and PDC in the population at large.
Results: From 1958 to 1999, there were 102 new ALS or PDC cases among relatives of patients and 33 among relatives of controls. These values were compared with the derived expected values. There were more observed than expected new cases among patients relatives, and less observed cases than expected among the controls relatives.
Conclusions: Relatives of patients with ALS or PDC have significantly higher risks for developing the disease than the Guamanian population, whereas relatives of controls have significantly lower risks.
This article has been cited by other articles:
![]() |
W. Sieh, Y. Choi, N. H. Chapman, U.-K. Craig, E. J. Steinbart, J. H. Rothstein, K. Oyanagi, R. M. Garruto, T. D. Bird, D. R. Galasko, et al. Identification of novel susceptibility loci for Guam neurodegenerative disease: challenges of genome scans in genetic isolates Hum. Mol. Genet., October 1, 2009; 18(19): 3725 - 3738. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Kim, X. Fan, C. Gabbi, K. Yakimchuk, P. Parini, M. Warner, and J.-A. Gustafsson Liver X receptor {beta} (LXR{beta}): A link between {beta}-sitosterol and amyotrophic lateral sclerosis-Parkinson's dementia PNAS, February 12, 2008; 105(6): 2094 - 2099. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Chen, M. Richard, D. P. Sandler, D. M. Umbach, and F. Kamel Head Injury and Amyotrophic Lateral Sclerosis Am. J. Epidemiol., October 1, 2007; 166(7): 810 - 816. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yang, R. L. Woltjer, I. Sokal, C. Pan, Y. Wang, M. Brodey, E. R. Peskind, J. B. Leverenz, J. Zhang, D. P. Perl, et al. Quantitative Proteomics Identifies Surfactant-Resistant {alpha}-Synuclein in Cerebral Cortex of Parkinsonism-Dementia Complex of Guam but Not Alzheimer's Disease or Progressive Supranuclear Palsy Am. J. Pathol., September 1, 2007; 171(3): 993 - 1002. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Galasko, D. Salmon, A. Gamst, J. Olichney, L. J. Thal, L. Silbert, J. Kaye, P. Brooks, R. Adonay, U.-K Craig, et al. Prevalence of dementia in Chamorros on Guam: Relationship to age, gender, education, and APOE Neurology, May 22, 2007; 68(21): 1772 - 1781. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Sundar, C.-E. Yu, W. Sieh, E. Steinbart, R. M. Garruto, K. Oyanagi, U.-K. Craig, T. D. Bird, E. M. Wijsman, D. R. Galasko, et al. Two sites in the MAPT region confer genetic risk for Guam ALS/PDC and dementia Hum. Mol. Genet., February 1, 2007; 16(3): 295 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Nilius, G. Owsianik, T. Voets, and J. A. Peters Transient Receptor Potential Cation Channels in Disease Physiol Rev, January 1, 2007; 87(1): 165 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Hermosura, H. Nayakanti, M. V. Dorovkov, F. R. Calderon, A. G. Ryazanov, D. S. Haymer, and R. M. Garruto A TRPM7 variant shows altered sensitivity to magnesium that may contribute to the pathogenesis of two Guamanian neurodegenerative disorders PNAS, August 9, 2005; 102(32): 11510 - 11515. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Morris, J. C. Steele, R. Crook, F. Wavrant-De Vrieze, L. Onstead-Cardinale, K. Gwinn-Hardy, N. W. Wood, M. Farrer, A. J. Lees, P. L. McGeer, et al. Genome-Wide Analysis of the Parkinsonism-Dementia Complex of Guam Arch Neurol, December 1, 2004; 61(12): 1889 - 1897. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Armon Western Pacific ALS/PDC and flying foxes: What's next? Neurology, August 12, 2003; 61(3): 291 - 292. [Full Text] [PDF] |
||||
![]() |
C. C. Plato, R. M. Garruto, D. Galasko, U.-K. Craig, M. Plato, A. Gamst, J. M. Torres, and W. Wiederholt Amyotrophic Lateral Sclerosis and Parkinsonism-Dementia Complex of Guam: Changing Incidence Rates during the Past 60 Years Am. J. Epidemiol., January 15, 2003; 157(2): 149 - 157. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-M. Chen, U. K. Craig, C.-T. Lee, R. Haddock, P. A. Cox, and O. W. Sacks Cycad neurotoxin, consumption of flying foxes, and ALS/PDC disease in Guam Neurology, November 26, 2002; 59(10): 1664 - 1665. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |